Medical Device Implants: Cybersecurity Risks and How to Protect Connected Implantable Devices

Last updated: May 2026

Medical device implants provide cost-effective prevention, diagnostic, and treatment capabilities that improve patient outcomes. Pacemakers regulate heart rhythms. Neurostimulators manage chronic pain. Implantable insulin pumps deliver precise medication doses. These devices increasingly rely on wireless connectivity and external network communication to function, transmitting patient data to care teams and receiving programming updates remotely. That connectivity makes them targets. H-ISAC reported a 74% year-over-year increase in cybersecurity incidents targeting connected medical devices in 2025, with implantable devices representing the fastest-growing attack category. This guide covers the types of medical device implants in clinical use, the cybersecurity risks each one carries, and what healthcare delivery organizations can do to protect patients and data.

---

On this page:

• What Are Medical Device Implants?
• Why Attackers Target Implantable Medical Devices
• Four Common Medical Device Implants and Their Cybersecurity Risks
• The Risk Profile for Medical Device Implants
• Regulatory Requirements for Implantable Device Security
• How to Monitor and Protect Medical Device Implants
• Medical Device Implants and Your IoMT Security Program

---

What Are Medical Device Implants?

Medical device implants (also called implantable medical devices, or IMDs) are devices that are placed inside or on the surface of the body to support organ functions, monitor physiological activity, deliver medication, or provide therapeutic stimulation. They combine biological tissue interaction with electronic hardware, software, and, in most modern versions, wireless network connectivity.

The category includes cardiac implants like pacemakers and implantable cardioverter defibrillators (ICDs), neurostimulators for chronic pain and neurological disorders, implantable drug delivery systems for conditions requiring long-term therapy, biosensors for real-time health assessment, and cochlear implants for hearing restoration.

What makes medical device implants a cybersecurity concern is their increasing reliance on wireless communication. Modern implantable devices transmit patient health data to care providers, receive remote programming adjustments, and connect to hospital networks for monitoring and maintenance. Each of these communication channels represents a potential attack surface.

The RunSafe Security 2026 Medical Device Cybersecurity Index found that 24% of healthcare facilities have experienced a cyberattack on a medical device, up from 22% in 2025. Of those that experienced an attack, 80% reported moderate or significant disruption to patient care, including delayed imaging, postponed procedures, and interruptions in critical care delivery. A separate Halcyon/Health-ISAC study found that in-hospital mortality increased by 33% during ransomware incidents affecting medical systems.

For healthcare delivery organizations, securing medical device implants is both a patient safety obligation and a regulatory requirement.

Why Attackers Target Implantable Medical Devices

Threat actors typically pursue low-effort, high-reward targets. Implantable medical devices often lack the security controls found in traditional IT endpoints, making them attractive for several reasons:

Patient safety as a pressure point. Some IMDs directly control bodily functions. A pacemaker regulates a patient’s heart rhythm. An insulin pump controls medication dosing. The ability to threaten unauthorized access to these devices gives attackers power in ransom negotiations, since healthcare organizations face pressure to pay when patient lives are at stake. In a political or criminal context, the ability to target a specific patient’s implanted device could serve geopolitical or personal objectives.

Financial gain beyond ransom. A successful, publicized attack against a specific manufacturer’s implanted device can affect that company’s stock price, regulatory standing, and market position. Attackers motivated by market manipulation or competitive sabotage may target devices for financial reasons that have nothing to do with the patient.

Access to protected health information. Medical device implants collect and transmit electronic protected health information (ePHI) as part of their monitoring functions. Attackers target these devices both for the data stored directly on them and as entry points into the broader hospital network where additional ePHI and other sensitive data reside. Medical records remain among the most valuable data categories on the dark web.

Patient tracking. IMDs that transmit data over wireless networks also share information about the patient’s physical location. Threat actors can exploit these signals for tracking purposes, creating risks for high-profile patients or individuals in sensitive situations.

Four Common Medical Device Implants and Their Cybersecurity Risks

The cybersecurity risks associated with implantable devices have been studied for over a decade. Early research in 2016 identified IMD risks to inform medical device regulation, and subsequent studies have validated and expanded on those findings. The four most commonly deployed categories of medical device implants each carry distinct security risks.

Implantable Cardioverter Defibrillators (ICDs) and Cardiac Pacemakers

ICDs deliver an electric shock to the heart when they detect a dangerous irregularity. They are used for patients at risk of death from arrhythmias, including those with a history of cardiac arrest, tachycardia (abnormally fast heartbeat), bradycardia (abnormally slow heartbeat), cardiomyopathy, or reduced heart-pumping function.

Pacemakers serve a related but distinct function: they send electrical impulses to the heart to maintain a steady rhythm, primarily for patients with bradycardia. Modern pacemakers store patient data and transmit it wirelessly to care providers for remote monitoring.

Both device types have documented cybersecurity vulnerabilities. In 2019, the FDA issued a safety communication about cybersecurity vulnerabilities in Medtronic’s implantable cardiac device programmers, and Medtronic acknowledged that its cardiac devices’ wireless telemetry technology could allow unauthorized access. Researchers have demonstrated the ability to wirelessly reprogram pacemaker settings, potentially altering heart rhythms in ways that could injure or kill a patient. St. Jude Medical (now Abbott) recalled nearly 500,000 pacemakers in 2017 for a firmware update addressing cybersecurity vulnerabilities.

An attack against these devices could lead to inappropriate shocks, therapy inhibition, battery depletion, or in extreme scenarios, cardiac arrest.

Deep Brain Stimulators (DBS)

A deep brain stimulation system consists of implanted electrodes connected to an implantable pulse generator (IPG) that delivers electrical stimulation to specific brain regions. DBS systems treat motor impairments and movement disorders (Parkinson’s disease, dystonia), chronic pain, and in some applications, psychiatric conditions like obsessive-compulsive disorder.

These devices are considered a subset of brain-computer interfaces (BCIs). Their therapeutic effects depend on precise electrical stimulation parameters.

In January 2026, researchers at a European university demonstrated the ability to wirelessly alter the therapy schedule of an implanted neurostimulator from 15 meters away using a modified Bluetooth Low Energy transceiver costing under $35. The device accepted the unauthorized commands without triggering any authentication challenge or logging the event.

An attack against a DBS system could increase patient pain, reduce motor function, or alter the patient’s emotional state by modifying stimulation parameters.

Implantable Drug Delivery Systems

Implantable drug delivery systems are battery-powered devices that enable healthcare providers to target medication delivery with precision. They are used for conditions requiring long-term therapy, including heart disease, diabetes, cancer, and chronic pain management. These systems deliver medication either locally or through systemic circulation, maintaining constant dosing at a predetermined rate.

Implantable insulin pumps are a common subtype. They mimic pancreatic activity by slowly releasing insulin throughout the day and adjusting delivery around mealtimes. The FDA recalled Medtronic MiniMed insulin pumps in 2019 after determining that someone nearby could connect to the device over a wireless connection and change dosage settings. Medtronic identified approximately 4,000 active devices affected and provided replacement pumps.

An attack against an implantable drug delivery system could cause a medication overdose or underdose, either of which could directly threaten patient health.

Bio-NanoThings and Biosensors

Bio-NanoThings are an emerging category of small, non-intrusive devices used for intra-body sensing and actuation networks. They support health monitoring, targeted drug delivery at the cellular level, and experimental nano-surgical applications. Many incorporate RFID sensors for real-time patient tracking and facility supply management.

While these devices are still early in clinical adoption, their reliance on wireless communication protocols and limited onboard security makes them susceptible to the same attack categories that affect more established implantable devices.

The Risk Profile for Medical Device Implants

Although these devices serve different clinical functions, they share common vulnerability categories that healthcare delivery organizations should understand and address.

Wireless Network Connectivity

Most modern medical device implants use wireless connectivity to log data periodically and share it with care providers as part of remote patient monitoring. Many of these devices were designed with functionality as the priority, not security. They may lack adequate authentication and authorization mechanisms, use weak or outdated encryption, or transmit data over protocols without integrity verification.

These gaps leave implantable devices vulnerable to man-in-the-middle attacks (intercepting and altering communications between the device and the monitoring system), message replay attacks (retransmitting captured commands), impersonation attacks (posing as a legitimate programmer or monitoring station), unauthorized modification of treatment parameters, remote device shutdown, and battery depletion through denial-of-service attacks that force the device to process excessive requests.

Operating System, Software, and Firmware Vulnerabilities

Like all connected technology, medical device implants run software that may contain exploitable vulnerabilities. The challenge is that patching these devices carries its own risks: firmware updates can deplete battery life, cause temporary device shutdown, introduce new vulnerabilities, or cause device malfunctions.

Healthcare delivery organizations and their clinical engineering teams must balance continued device availability with security when evaluating whether to apply updates. The priority should be updates that respond to actively exploited or high-likelihood threats, evaluated in the context of the device’s network exposure and the compensating controls already in place.

RFID Sensor Risks

Implantable devices that incorporate RFID sensors for tracking and identification are susceptible to hardware trojans that modify RFID tags and allow an attacker access to device software, side-channel attacks that intercept information during data exchanges, tag cloning to steal patient information or impersonate the device, and tag counterfeiting by gaining access to the tag and modifying its identity.

Third-Party Vendor and Supply Chain Risk

The third-party risk for medical device implants falls into two categories: connected applications that care teams use to modify device settings and monitor patients, and manufacturer data protection practices.

Third-party risk is not theoretical. In January 2023, Insulet Corporation experienced a data privacy incident affecting Omnipod DASH insulin pump customers. A web page used to verify receipt of a Medical Device Correction shared customer data, including IP addresses and device usage information, with third-party marketing and analytics partners through cookies. The incident highlighted how vendor data handling practices can expose patient information even without a traditional cyberattack.

FDA Section 524B now requires manufacturers to implement security throughout the product lifecycle, including documenting software components through Software Bills of Materials (SBOMs), managing vulnerabilities, and maintaining secure development processes. The 2026 RunSafe index found that 81% of healthcare organizations rate SBOMs as “important” or “essential,” and 35% will not consider a device without one.

Regulatory Requirements for Implantable Device Security

The regulatory environment for medical device implant security has tightened considerably in recent years:

FDA Section 524B requires manufacturers to build cybersecurity into device design, maintain SBOMs, and develop plans for addressing vulnerabilities throughout the product lifecycle. This applies to all new device submissions and has raised the security baseline for implantable devices entering the market.

HIPAA Security Rule requires covered entities to protect ePHI, which includes data generated and transmitted by implantable medical devices. The 2026 HIPAA Security Rule update tightens requirements further.

State-level mandates are expanding. New York’s 10 NYCRR 405.46 established the first state-level hospital cybersecurity regulation. Texas HHSC issued a cybersecurity directive in March 2026 requiring healthcare facilities to review their connected medical device security.

FDA safety communications provide device-specific cybersecurity alerts. Healthcare organizations should have a process for monitoring FDA safety communications and acting on those relevant to their implantable device inventory. Asimily’s platform integrates FDA recall and safety advisory monitoring so security teams are notified when a device in their environment is affected.

Related: Medical Device Security Standards: What HDOs Need to Know

Related: New York’s Hospital Cybersecurity Regulation (10 NYCRR 405.46)

Related: New Texas HHSC Cybersecurity Directive

How to Monitor and Protect Medical Device Implants

Medical device implants present the same security management challenges as other IoMT devices, compounded by the direct patient safety implications of compromise. Healthcare delivery organizations can reduce risk through several complementary strategies:

Complete Device Inventory

You cannot secure implantable devices that you do not know are on your network. Inventory should cover every connected medical device, including implant programmer stations, remote monitoring hubs, and the network infrastructure that carries implant telemetry data. Passive discovery is essential in clinical environments, since active scanning can disrupt sensitive medical equipment.

Asimily’s passive deep packet inspection discovers and classifies IoMT devices, including implant communication infrastructure, without sending traffic that could disrupt clinical equipment. The platform identifies device manufacturer, model, firmware version, communication patterns, and known vulnerabilities automatically.

Contextual Vulnerability Prioritization

The average medical device carries 6.2 vulnerabilities, and 60% of medical devices in active use are end-of-life with no available security patches. Addressing every vulnerability equally is not feasible. Prioritization must account for network exposure, exploit availability, device criticality, and patient safety implications.

Asimily’s vulnerability prioritization uses analysis from Asimily Labs, AI/ML techniques, and the MITRE ATT&CK framework for attack path analysis. The platform determines whether a vulnerability on a specific device in a specific network context is realistically exploitable, reducing the actionable list by an order of magnitude.

Network Segmentation

Implantable device monitoring systems should not sit on the same network segment as general-purpose IT systems. Segmentation limits the damage an attacker can do if they compromise a device programmer or monitoring station, preventing lateral movement into the broader hospital network.

Asimily generates segmentation policies based on observed device communication patterns and integrates with existing NAC platforms (including Cisco ISE), firewalls, and switch infrastructure. The Policy Simulation feature allows teams to preview policy effects before enforcement, avoiding disruptions to clinical workflows.

Pre-Purchase Security Assessment

Evaluating device security before procurement is the most cost-effective risk reduction strategy. Healthcare organizations should assess manufacturer security practices, patching commitments, SBOM availability, and end-of-life policies before purchasing new implantable devices or their associated monitoring infrastructure.

Asimily’s ProSecure database provides pre-purchase security risk profiles for medical devices, including implant programmers and monitoring systems, allowing procurement and security teams to make informed decisions before devices enter the clinical environment.

Behavioral Monitoring and Incident Response

Continuous monitoring of network traffic from implantable device infrastructure can detect anomalous communication patterns that indicate compromise: unexpected destinations, unusual data volumes, protocol deviations, or unauthorized programming attempts. When detection triggers, having the forensic data and device context to respond effectively is critical.

Asimily provides packet capture on detection events and device-level context (manufacturer, firmware, communication history, clinical department) that helps incident responders make safe containment decisions that balance security with patient care continuity.

Related: CISO’s Security Risk Assessment Guide for Medical Device Procurement

Related: Forensic Analysis Guide for IoMT Cybersecurity

Related: FDA Recalls and Security Advisories

Medical Device Implants and Your IoMT Security Program

Medical device implants are one component of a broader IoMT environment that includes infusion pumps, imaging systems, patient monitors, laboratory equipment, and the network infrastructure that connects them. Securing implantable devices in isolation is not sufficient; they must be managed as part of a comprehensive connected device security program.

Healthcare delivery organizations need a platform that provides visibility across all connected medical devices, prioritizes vulnerabilities based on clinical risk, automates segmentation policy creation, monitors for behavioral anomalies, and supports rapid incident response when something goes wrong.

Asimily provides this capability across IoMT, IoT, OT, and IT environments from a single platform. From pre-purchase risk assessment through operational monitoring and end-of-life management, the platform addresses the full lifecycle of connected medical devices, including the implantable devices that are most directly tied to patient safety.

---

Asimily is the next-generation cyber asset and exposure management platform for IT, IoT, OT, and IoMT environments. Learn more about our platform.